Stockscreener 앱 받기
0.3367
0.69%
0.0023
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
HC Wainwright Has Pessimistic Outlook of HRTX Q3 Earnings - MarketBeat
H.C. Wainwright Downgrades Heron Therapeutics(HRTX.US) to Hold Rating - Moomoo
Heron Therapeutics earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ... - finance.yahoo.com
Heron Therapeutics Q2 2026 Loss Widens 50.0% Beyond Estimates - AlphaStreet
Heron Therapeutics: Q2 Earnings Snapshot - AOL.com
Heron Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Heron Therapeutics Q2 2026 Earnings Call Transcript - MarketBeat
Heron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook - Yahoo Finance
Earnings call transcript: Heron Therapeutics misses Q2 2026 revenue forecast By Investing.com - Investing.com Canada
Heron Therapeutics Q2 Earnings Call Highlights - MarketBeat
Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
development in the article - Minichart
Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results - MarketBeat
HERON THERAPEUTICS INC HERON TH (0J4V.L) Q2 FY2026 earnings call transcript - Yahoo Finance
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook - TradingView
Heron Therapeutics Q2 Revenue Rises To $37.7 Million - Quiver Quantitative
Heron Therapeutics reports Q2 2026 revenue $37.7M, withdraws 2026 guidance after patent ruling - TradingView
Heron Therapeutics Announces Second Quarter 2026 Financial Results - marketscreener.com
Heron Therapeutics (HRTX) Earnings Date and Reports 2026 $HRTX - MarketBeat
Wall Street Zen Upgrades Heron Therapeutics (NASDAQ:HRTX) to Sell - MarketBeat
HERON THERAPEUTICS Q2 2026 Earnings Preview: Recent $HRTX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Heron Therapeutics Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Upgraded to Hold at Zacks Research - MarketBeat
Earnings Preview: HRTX to Report Financial Results Pre-market on August 10 - Moomoo
HRTX Q2'26 Earnings: revenue estimate is 42.19M USD - TradingView
Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Monday - MarketBeat
Heron Therapeutics, Inc. Revenue Breakdown – NASDAQ:HRTX - TradingView
Heron Therapeutics Inc (HRTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Heron Therapeutics Inc Revenue Breakdown – BX:AXD2 - TradingView
Heron Therapeutics Inc (HRTX) Institutional Confidence - TradingKey
Heron Therapeutics to Report Second Quarter 2026 Financial Results on August 10 - Quiver Quantitative
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026 - The Manila Times
Orbimed Advisors LLC Makes New Investment in Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics Inc (HRTX) Cash Flow - TradingKey
Heron Therapeutics Inc (AXD2) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? - Stocktwits
Heron Therapeutics Inc (AXD2) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Heron Therapeutics Inc (HRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Heron Therapeutics Inc (HRTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HRTX|Heron Therapeutics Inc|Price:0.456|Chg%:-0.003 - TradingKey
Heron Therapeutics Inc (HRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - tradingkey.com
VOO Stock Price TodayVanguard S&P 500 ETF News, Charts, Retail Sentiment - Stocktwits
Heron Therapeutics Inc (AXD2) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Heron Therapeutics Inc (AXD2) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Heron Therapeutics Inc (AXD2) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Heron Therapeutics Inc (HRTX) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
HRTX Stock Price, Quote & Chart - ChartMill
Heron Therapeutics Inc (HRTX) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
HRTX Q1 2026 Earnings: Significant EPS Miss Amid Modest Stock GainDividend Increase Stocks - dars.gov.et
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision - Yahoo Finance
Heron Therapeutics updates investors on business progress as development pipeline remains the key va - Ad-hoc-news.de
HRTXHeron Therapeutics Inc Options - Finviz
Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent Court Ruling? - Insider Monkey
Heron Therapeutics Inc (HRTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Heron Therapeutics Faces Nasdaq Minimum Bid Price Deficiency - The Globe and Mail
Heron Therapeutics Receives Nasdaq Minimum Bid Price Notification - Moomoo
0.52%
0.07%
자본화:
|
볼륨(24시간):